Indo-Bangla Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Indo-Bangla Pharmaceuticals has a total shareholder equity of BDT1.6B and total debt of BDT35.0M, which brings its debt-to-equity ratio to 2.2%. Its total assets and total liabilities are BDT1.9B and BDT250.9M respectively.
Key information
2.2%
Debt to equity ratio
৳35.01m
Debt
| Interest coverage ratio | n/a |
| Cash | ৳10.48m |
| Equity | ৳1.61b |
| Total liabilities | ৳250.90m |
| Total assets | ৳1.86b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IBP's short term assets (BDT531.7M) exceed its short term liabilities (BDT113.9M).
Long Term Liabilities: IBP's short term assets (BDT531.7M) exceed its long term liabilities (BDT137.0M).
Debt to Equity History and Analysis
Debt Level: IBP's net debt to equity ratio (1.5%) is considered satisfactory.
Reducing Debt: IBP's debt to equity ratio has increased from 0% to 2.2% over the past 5 years.
Debt Coverage: IBP's debt is well covered by operating cash flow (252.5%).
Interest Coverage: Insufficient data to determine if IBP's interest payments on its debt are well covered by EBIT.